Results 161 to 170 of about 56,364 (301)

Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults [PDF]

, 2015
Myron J. Levin, Kenneth E. Schmader, Lei Pang, Angela Williams‐Diaz, Gary O. Zerbe, Jennifer Canniff, Michael Johnson, Yupanqui Caldas, Alice Cho, Nancy Lang, Shu‐Chih Su, Janie Parrino, Zoran Popmihajlov, Adriana Weinberg   +13 more
openalex   +1 more source

Herpes zoster ophthalmicus in two women after Pfizer–BioNTech (BNT162b2) vaccine [PDF]

, 2021
Nicoletta Bernardini, Nevena Skroza, Alessandra Mambrin, Ilaria Proietti, Anna Marchesiello, Federica Marraffa, Giovanni Rossi, Salvatore Volpe, Ersilia Tolino, Concetta Potenza   +9 more
openalex   +1 more source

Efficacy, Immunogenicity and Safety of an Investigational Subunit Adjuvanted Herpes Zoster Vaccine in Adults Aged 60 Years and Older: Results From the ZOE-50 and ZOE-70 Efficacy Studies [PDF]

, 2016
Janet E. McElhaney, Himal Lal, Anthony L. Cunningham, Myron J. Levin, Roman Chlíbek, Javier Díez‐Domingo, Eugene Athan, Johan Berglund, H. Jackson Downey, Wayne Ghesquière, Olivier Godeaux, Iris Gorfinkel, Shinn‐Jang Hwang, Tiina Korhonen, Shelly McNeil, Karlis Pauksens, Joan Puig‐Barberà, Thiago Junqueira Avelino‐Silva, Timo Vesikari, Antonio Volpi, Daisuke Watanabe, Wilfred Yeo, Laura Cámpora, Carline Vanden Abeele, Lidia Oostvogels, Thomas C. Heineman   +25 more
openalex   +1 more source

Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine

npj Vaccines
Varicella zoster virus (VZV) is a highly contagious human herpes virus responsible for causing chickenpox (varicella) and shingles (herpes zoster). Despite the approval of a highly effective vaccine, Shingrix®, the global incidence of herpes zoster is ...
Anannya Bhattacharya, Lonzaric Jan, Olga Burlak, Jilong Li, Ghanshyam Upadhyay, Katherine Williams, Jinhui Dong, Harrison Rohrer, Michelle Pynn, Andrew Simon, Nathan Kuhlmann, Sergei Pustylnikov, Mariane B. Melo, Antu K. Dey   +13 more
doaj   +1 more source

A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine. [PDF]

Am J Epidemiol, 2022
Yih WK, Kulldorff M, Dashevsky I, Maro JC.   +3 more
europepmc   +1 more source

Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older [PDF]

, 2016
Héctor S. Izurieta, Michael Wernecke, Jeffrey A. Kelman, Sarah Anne Wong, Richard A. Forshee, Douglas Pratt, Yun Lu, Qin Sun, Christopher Jankosky, Philip R. Krause, Chris Worrall, Tom MaCurdy, Rafael Harpaz   +12 more
openalex   +1 more source

The Importance of Vaccination against Herpes Zoster [PDF]

Ophthalmology, 2021
openaire   +3 more sources

Herpes zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in New Zealand: a retrospective cohort study. [PDF]

Lancet Reg Health West Pac, 2023
Mbinta JF, Wang AX, Nguyen BP, Paynter J, Awuni PMA, Pine R, Sporle AA, Simpson CR.   +7 more
europepmc   +1 more source

Development of antibody-dependent cellular cytotoxicity in response to recombinant and live-attenuated herpes zoster vaccines [PDF]

, 2022
Seong Yeon Park, Myron J. Levin, Jennifer Canniff, Michael Johnson, D. Scott Schmid, Adriana Weinberg   +5 more
openalex   +1 more source

Development of a perfusion process for serum-free adenovirus vector herpes zoster vaccine production. [PDF]

AMB Express, 2022
Sun Y, Huang L, Nie J, Feng K, Liu Y, Bai Z.   +5 more
europepmc   +1 more source